4/1
01:04 pm
cnta
Centessa Pharmaceuticals plc (NASDAQ: CNTA) had its "outperform" rating re-affirmed by analysts at BMO Capital Markets. They now have a $15.00 price target on the stock.
Low
Report
Centessa Pharmaceuticals plc (NASDAQ: CNTA) had its "outperform" rating re-affirmed by analysts at BMO Capital Markets. They now have a $15.00 price target on the stock.
4/1
12:24 pm
cnta
Rating for CNTA
Low
Report
Rating for CNTA
4/1
12:24 pm
cnta
Rating for CNTA
Low
Report
Rating for CNTA